Ginkgo Bioworks Holdings Inc (DNA)
7.285
-1.32
(-15.29%)
USD |
NYSE |
Nov 14, 16:00
7.37
+0.08
(+1.17%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Profit Margin (Quarterly): -386.4% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -386.4% |
| March 31, 2024 | -437.3% |
| December 31, 2023 | -609.1% |
| September 30, 2023 | -546.4% |
| June 30, 2023 | -215.1% |
| March 31, 2023 | -254.0% |
| December 31, 2022 | -178.5% |
| September 30, 2022 | -1.01K% |
| Date | Value |
|---|---|
| June 30, 2022 | -462.5% |
| March 31, 2022 | -350.6% |
| December 31, 2021 | -1.08K% |
| September 30, 2021 | -131.3% |
| June 30, 2021 | -123.6% |
| March 31, 2021 | -166.8% |
| December 31, 2020 | -146.4% |
| September 30, 2020 | -195.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.08K%
Minimum
Dec 2021
-123.6%
Maximum
Jun 2021
-393.2%
Average
-302.3%
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| UnitedHealth Group Inc | 6.11% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.11% |
| Return on Assets | -48.84% |
| Return on Invested Capital | -79.11% |
| Gross Profit Margin (Quarterly) | 75.59% |
| Operating Margin (Quarterly) | -281.1% |
| Return on Net Operating Assets | -125.7% |